Stephen Willey
Stock Analyst at Stifel
(2.26)
# 2,437
Out of 4,814 analysts
131
Total ratings
34.38%
Success rate
-1.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Maintains: Buy | $36 → $35 | $9.32 | +275.54% | 5 | Apr 9, 2025 | |
| NKTX Nkarta | Maintains: Buy | $15 → $14 | $1.72 | +713.95% | 3 | Mar 27, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $1.5 → $1.25 | $0.34 | +270.92% | 3 | Mar 25, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $12 → $5 | $0.65 | +669.23% | 5 | Mar 21, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $12 → $10 | $2.42 | +314.08% | 5 | Feb 28, 2025 | |
| GERN Geron | Maintains: Buy | $8 → $4 | $1.27 | +216.21% | 3 | Feb 27, 2025 | |
| INSM Insmed | Maintains: Buy | $97 → $96 | $72.47 | +32.47% | 6 | Feb 21, 2025 | |
| EXEL Exelixis | Maintains: Hold | $30 → $36 | $36.06 | -0.17% | 17 | Feb 12, 2025 | |
| INCY Incyte | Maintains: Hold | $75 → $77 | $58.22 | +32.26% | 5 | Feb 10, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $27 → $2.5 | $1.24 | +102.43% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $0.19 | +1,983.33% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $11.54 | +142.63% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $12.13 | +287.63% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.80 | +399.94% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $1.69 | +77.51% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $29 → $7 | $1.27 | +451.18% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $1.97 | +256.09% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.49 | +168.46% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $35.16 | +76.36% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.77 | +409.92% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.80 | +566.67% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.74 | +16,451.72% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $0.78 | +2,600.96% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $0.51 | +684.16% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $234.75 | -47.60% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $28.32 | +65.96% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $59.12 | +84.37% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $18.27 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $0.22 | +11,025.95% | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $4.33 | +431.79% | 5 | Feb 7, 2018 |
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $9.32
Upside: +275.54%
Nkarta
Mar 27, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $1.72
Upside: +713.95%
Bolt Biotherapeutics
Mar 25, 2025
Maintains: Hold
Price Target: $1.5 → $1.25
Current: $0.34
Upside: +270.92%
Vor Biopharma
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $0.65
Upside: +669.23%
AbCellera Biologics
Feb 28, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.42
Upside: +314.08%
Geron
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.27
Upside: +216.21%
Insmed
Feb 21, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $72.47
Upside: +32.47%
Exelixis
Feb 12, 2025
Maintains: Hold
Price Target: $30 → $36
Current: $36.06
Upside: -0.17%
Incyte
Feb 10, 2025
Maintains: Hold
Price Target: $75 → $77
Current: $58.22
Upside: +32.26%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $27 → $2.5
Current: $1.24
Upside: +102.43%
Nov 14, 2024
Maintains: Buy
Price Target: $5 → $4
Current: $0.19
Upside: +1,983.33%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $11.54
Upside: +142.63%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $12.13
Upside: +287.63%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.80
Upside: +399.94%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.69
Upside: +77.51%
May 10, 2024
Downgrades: Hold
Price Target: $29 → $7
Current: $1.27
Upside: +451.18%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $1.97
Upside: +256.09%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.49
Upside: +168.46%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $35.16
Upside: +76.36%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $1.77
Upside: +409.92%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.80
Upside: +566.67%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.74
Upside: +16,451.72%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $0.78
Upside: +2,600.96%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $0.51
Upside: +684.16%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $234.75
Upside: -47.60%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $28.32
Upside: +65.96%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $59.12
Upside: +84.37%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $18.27
Upside: -
Mar 7, 2018
Maintains: Buy
Price Target: $23 → $25
Current: $0.22
Upside: +11,025.95%
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $4.33
Upside: +431.79%